Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?

To: DavidCG who wrote (26432)	12/11/1998 12:51:00 PM
From: Tom Latham	Read Replies (1) \| Respond to of 119973

Every vet in the world is going to give FIDO a shot in the butt with this stuff if he/she is over 7 years old../// DRAXF

To: DavidCG who wrote (26432)	12/11/1998 12:51:00 PM
From: Panita	Respond to of 119973

DRAXF - why not volume now high enough to get notice

To: DavidCG who wrote (26432)	12/11/1998 1:00:00 PM
From: brent gephart	Read Replies (1) \| Respond to of 119973

No, I get it. BECTON DICKINSON symbol BDX, 3.2 Billion in sales. They own all of the Diabetes market in all the drug stores,hospitals and doctors offices in the US and most of the world. B&D was going to mass market JMAR's Lightknife which JMAR designed for them. We saw the idea we all thought it was great at the JMAR thread, and it never came about. I think you need to look at B&D to see just how LARGE this company is and how much market share they have. Trust me, I want CRII to succeed becuase B&D will than go ahead with JMAR's lightknife. But for now enjoy the press while its there for you. Brent

To: DavidCG who wrote (26432)	12/11/1998 1:01:00 PM
From: keta	Read Replies (2) \| Respond to of 119973

<CRII is well positioned in the doctors office, hospitals, and MOST IMPORTANTLY...the 100 million worldwide DIABETIC population or consumer market....And that would be a $10 BILLION dollar market with no competition for at least 2-3 years down the road.> Actually, though CRII has a head start, there are many companies working on non-invasive glucose monitoring technologies (Cygnus comes to mind). My wife is diabetic and wouldn't even consider CRII's product for her personal use unless it was covered by insurance, or cheap, and completely portable. Yes the market is huge, but CRII are a long way from cornering it. - Lee